ScreenerHero

CDVA CordovaCann Corp.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · cordovacann.com
0.0250CAD0.00%Mkt Cap: 2.00M $P/E: —

CordovaCann Corp. engages in the provision of services and investment capital to the processing, production, and retail vertical markets of the cannabis industry in Canada and United States. The company was formerly know…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap2.00M USD
Enterprise Value5.75M USD
Revenue (TTM)9.99M USD
Gross Profit3.03M USD
Net Income (TTM)-1.96M USD
Revenue/Share0.13 CAD
Last Price0.0250 CAD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA21864T1075
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA12.06
EV/Revenue0.58
P/S0.20
P/B-0.44
EPS (TTM)-0.02
EPS (Forward)—
52W Range
0.005027% of range0.0800
52W High0.0800 CAD
52W Low0.0050 CAD
Profitability
Gross Margin29.24%
Oper. Margin4.47%
EBITDA Margin4.77%
Profit Margin-18.88%
ROE46.34%
ROA-42.00%
Growth
Revenue Growth-9.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF830.36K USD
CapEx (TTM)12.15K USD
FCF Margin6.75%
FCF Yield33.72%
Net Debt3.39M USD
Net Debt/EBITDA7.12
Balance Sheet
Debt/Equity-0.86
Current Ratio0.18
Quick Ratio0.07
Book Value/Sh-0.06 CAD
Cash/Share0.0050 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.109.80M
Float98.65M
Insiders10.16%
Institutions2.68%
Short Interest
Short Ratio0.8d
Short % Float0.00%
Short % Out.0.00%
Shares Short590
Short (prev mo.)1.39K
Technical
SMA 500.0326 (-23.3%)
SMA 2000.0341 (-26.7%)
Beta-0.24
S&P 52W Chg16.45%
Avg Vol (30d)6.45K
Avg Vol (10d)7.50K
Technical Indicators
RSI (14)43.8
MACD-0.0021
MACD Signal-0.0031
MACD Hist.+0.0010
BB Upper0.0322 CAD
BB Middle0.0222 CAD
BB Lower0.0123 CAD
BB Width89.77%
ATR (14)0.0014 CAD
Vol Ratio (20d)0.00x